Mylan Pharmaceuticals Inc. et al. vs. Pfizer Inc.
Explore the PTAB proceeding IPR2018-01361 filed by Mylan Pharmaceuticals Inc. et al. on 2018-07-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-01361
Filing Date
2018-07-10
Accorded Filing Date
2018-07-10
Institution Decision Date
2018-10-11
Last Modified Date
2024-01-11
Proceeding Type
IPR
Termination Date
2018-10-11
Trial Status
Terminated
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
Parmelee, Stevenet alPatent Owner / Respondent
Pfizer Inc.
Represented By
Maurer, Aaronet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Terminated
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34462 | Bryan Zielinski | +1 858-755-5925 |
| 40784 | Jeffrey Rennecker | +1 858-622-8850 |
| 41213 | Jeffrey Myers | +1 212-733-5061 |
| 42640 | Suzanne Bates | +1 734-622-2658 |
| 43080 | Lisa Samuels | +1 860-686-0349 |
| 45051 | Chase Romick | +1 212-733-8054 |
| 46319 | Christian Smolizza | +1 212-733-9094 |
| 48032 | John Wichtowski | +1 860-715-6645 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 16 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,572,823 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,566,290 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 65,406,005 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 75,522,705 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 7,582,621 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 74,636,106 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 7,767,657 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,039,451 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,115,026 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,440,642 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,722,917 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,889,656 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,353,133 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2015011936 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,566,289 B2 | US Continuation / Sibling | View Official Patent → |
Mylan Pharmaceuticals Inc. et al. v. Pfizer Inc.
Mylan Pharmaceuticals Inc. et al. v. Pfizer Inc.
FlatWing Pharmaceuticals, LLC et al. v. Anacor Pharmaceuticals, Inc. et al.
FlatWing Pharmaceuticals, LLC et al. v. Anacor Pharmaceuticals, Inc. et al.
FlatWing Pharmaceuticals, LLC et al. v. Anacor Pharmaceuticals, Inc. et al.
Coalition for Affordable Drugs X LLC v. Anacor Pharmaceuticals, Inc.